Relationship Between HbA1c Level, Sleep Quality and Sleep Duration

Sponsor
University of Hertfordshire (Other)
Overall Status
Completed
CT.gov ID
NCT04032561
Collaborator
(none)
100
1
7.9
12.6

Study Details

Study Description

Brief Summary

The study will be conducted during the period of, January 2019 - August 2019 with pre-diabetic participants on a NHS England funded National Diabetes Prevention Program (NDPP) with a clinically diagnosed Haemoglobin A1c (HbA1c) referral reading of between 42mmol/mol - 47mmol/mol within the last 12 months. The term pre-diabetic can all be used to explain blood glucose levels that are higher than normal, but not high enough for participants to be diagnosed with Type 2 diabetes. Having high blood glucose levels can increase a participant's risk of developing Type 2 diabetes and other health complications, although this is not inevitable.

100 participants will take part in the study. Participants will be eligible if they are aged between 18 and 65 years and have an HbA1c referral reading of between 42-47mmol/mol within the last 12 months.

The participants will be given a written consent form to sign to take part in the study, after receiving both written and verbal information beforehand on the study protocol from the researcher. Health screening to determine eligibility for the NHS funded program will be undertaken directly by the intervention provider.

Study design and procedures:

The study will be delivered in a controlled format and will be designed to assess the relationship between the elevation of HbA1c level, sleep quality and sleep duration in clinically diagnosed pre-diabetic participants referred and registered to join the NHS NDPP. Participants will receive a pre-program information pack in conjunction with a sleep quality and sleep duration questionnaire at the end of their 1:1 initial appointments for the NHS NDPP.

Participants will be given prepaid envelopes to send their anonymised questionnaires back to the researcher once completed after their appointments. The researcher will ensure confidentiality by keeping all questionnaires in a securely combination coded locked cupboard that only the researcher has access to. Participants will be instructed to not write their names on the questionnaires but to only state their gender, age, and referral HbA1c reading received from the relevant health care professional.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    100 participants
    Observational Model:
    Cohort
    Time Perspective:
    Retrospective
    Official Title:
    The Relationship Between the Elevation of Haemoglobin A1c Level, Sleep Quality and Sleep Duration in Clinically Diagnosed Pre-diabetic Patients in a Nationally Representative Sample
    Actual Study Start Date :
    Jan 8, 2019
    Actual Primary Completion Date :
    Sep 6, 2019
    Actual Study Completion Date :
    Sep 6, 2019

    Outcome Measures

    Primary Outcome Measures

    1. Sleep Quality [1 month]

      Sleep quality was measured from PSQI. Scoring system: Not during the past month = 0 Less than once a week = 1 Once or twice a week = 2 Three or more times a week = 3

    2. Sleep Duration [1 month]

      Sleep duration was measured from PQSI. Scoring system: Not during the past month = 0 Less than once a week = 1 Once or twice a week = 2 Three or more times a week = 3

    Secondary Outcome Measures

    1. HbA1c [Within 12 months]

      Retrieved from NHS referral database

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Participants were eligible if they were aged 18 years - 65 years

    • Had an HbA1c referral reading of between 42-47mmol/mol within the last 12 months

    • Registered on the NHSE NDPP

    Exclusion Criteria:
    • Participants with a severe debilitating disease which may have interfered with the study participation

    • Under the age of 18 years or over the age of 65 years

    • Pregnant

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 NHS/HSC Site London United Kingdom NW5 2BX

    Sponsors and Collaborators

    • University of Hertfordshire

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Terun Desai, Lead Investigator, University of Hertfordshire
    ClinicalTrials.gov Identifier:
    NCT04032561
    Other Study ID Numbers:
    • LMS/UG/NHS/02928
    First Posted:
    Jul 25, 2019
    Last Update Posted:
    Nov 3, 2020
    Last Verified:
    Nov 1, 2020
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Terun Desai, Lead Investigator, University of Hertfordshire
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 3, 2020